课题基金 / 基金详情

Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis

Senescent CD8+ T and NK cells contribute to immunopathogy duting cutaneous leishmaniasis
衰老的 CD8 T 和 NK 细胞导致皮肤利什曼病的免疫病理
批准号:
MR/T015853/1
负责人:
Arne Akbar
金额:
$93.31万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

Arne Akbar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Parasites belonging to the genus Leishmania are among the most diverse of human pathogens, both in terms of geographical distribution and in the variety of clinical syndromes caused by them. Currently, 12 million people are infected worldwide in 88 tropical/subtropical countries, 2 million new infections are reported annually, and 350 million people are under infection risk. In the past decade, the number of cases in endemic areas has increased sharply. In addition, leishmaniasis is spreading to several non-endemic areas of the world due to coinfections with HIV. Control measures currently available are case detection and treatment with drugs, which are expensive, not always available and cannot be self-administered. The problem is further aggravated by the surge of drug resistance parasites necessitating the development of an anti-Leishmania vaccine or other immunological therapies urgent.Research has demonstrated the importance of the immunity in controlling both cutaneous and mucocutaneous leishmaniasis, however the severe skin lesions that develop at the infected site is largely due to non-specific tissue damage but the reasons for this are unclear. The majority of this work has been performed on blood samples taken from patients and not from the site of infection at the skin. In this context, a unique feature of the current proposal is that we will be investigating the blood as well as the skin from the same patients, taken from both lesional and non-lesional sites. The main hypothesis of this grant application is that the severity of cutaneous immunopathology in infected individuals is due to non-specific damage mediated by both two types of immune cell namely the natural killer (NK) cells and a type of T cell that represent the "Dad's Army" of the immune system. Both these cell types are probably not triggered by the parasite in the skin lesions, instead they recognize decoy molecules in non-infected skin cells that cause them to be destroyed. This results in the large skin lesions that contain few parasites but huge numbers of dangerous white cells. In this study we will investigate the nature of the white cells in the skin lesions of patients. We will identify the decoy receptors that promote the non-specific tissue damage. We will also look at the wide array of genes that are activated in the skin to identify clue of how the interactions between the immune system and the skin are organized. We will also identify genes that will give us clues as to what other processes may be occurring that do not allow the lesions to resolve. In other parts of the study we will mimic the interaction of cell that are in the skin by growing them in a test tube to probe their interactions and find a way to block them. Finally we will investigate the involvement of a set off molecules known as sestrins, that we previously showed were involved in setting up the decoy mechanisms that may lead to skin lesion formation in patients with cutaneous leishmaniasis.As added value to this proposal, The Federal University of Espirito Santo will contribute 1 Technician and 1 PhD student to work on aspects of this grant.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.
皮肤利什曼病皮肤病变的转录组学景观揭示了与免疫病理学相关的强烈 CD8 T 细胞免疫衰老特征。
DOI: 10.1111/imm.13410
发表时间: 2021
期刊: Immunology
影响因子: 6.4
作者: [Fantecelle CH]
通讯作者: Fantecelle CH
The role of senescent T cells in immunopathology.
衰老T细胞在免疫病理学中的作用。
DOI: 10.1111/acel.13272
发表时间: 2020-12
期刊: Aging cell
影响因子: 7.8
作者: [Covre LP, De Maeyer RPH, Gomes DCO, Akbar AN]
通讯作者: Akbar AN
DOI: 10.3389/fimmu.2021.632667
发表时间: 2021
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Garcia de Moura R, Covre LP, Fantecelle CH, Gajardo VAT, Cunha CB, Stringari LL, Belew AT, Daniel CB, Zeidler SVV, Tadokoro CE, de Matos Guedes HL, Zanotti RL, Mosser D, Falqueto A, Akbar AN, Gomes DCO]
通讯作者: Gomes DCO
DOI: 10.1093/cei/uxad074
发表时间: 2023-12-11
期刊: CLINICAL AND EXPERIMENTAL IMMUNOLOGY
影响因子: 4.6
作者: [Ligotti,Mattia Emanuela, Accardi,Giulia, Candore,Giuseppina]
通讯作者: Candore,Giuseppina
Mechanism for CD8+ T cell recognition and removal of senescent tissue cells during ageing
  • 批准号:
    BB/Y003365/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $102.14万
  • 财政年份:
    2024
  • 负责人:
    Arne Akbar
  • 依托单位:
Establishing a network to catalyse collaboration for reducing immune ageing (CARINA: CAtalyst Reducing ImmuNe Ageing)
  • 批准号:
    BB/W018225/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $39.64万
  • 财政年份:
    2022
  • 负责人:
    Arne Akbar
  • 依托单位:
How does blocking inflammation enhance human cutaneous immunity during ageing in vivo?
  • 批准号:
    MR/T030534/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $109.01万
  • 财政年份:
    2020
  • 负责人:
    Arne Akbar
  • 依托单位:
Characterization of Leishmania-Specific T cells in human skin and blood during cutaneous and mucocutaneous leishmaniasis
  • 批准号:
    MR/N017749/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $14.85万
  • 财政年份:
    2016
  • 负责人:
    Arne Akbar
  • 依托单位:
国内基金
海外基金
糖脂代谢重塑型金属多酚纳米药物促进CD8+ T细胞活化浸润增效PD-1抗体治疗三阴性乳腺癌的研究
  • 批准号:
    2026JJ50635
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘芙蓉
  • 依托单位:
前列腺癌CD8+ T细胞雄激素受体表达介导内分泌治疗耐药的机制研究
  • 批准号:
    JCZRLH202601667
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Leptin通过调控MxA表达促进CD8+ T细胞活化参与白癜风发生发展的作用机制研究
  • 批准号:
    2026JJ81680
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    张慧明
  • 依托单位:
CD8+ T细胞衰老的代谢调控研究
  • 批准号:
    JCZRQNA202600019
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: